CD36 Mediates the Innate Host Response to β-Amyloid
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Accumulation of inflammatory microglia in Alzheimer's senile plaques is a hallmark of the innate response to β-amyloid fibrils and can initiate and propagate neurodegeneration characteristic of Alzheimer's disease (AD). The molecular mechanism whereby fibrillar β-amyloid activates the inflammatory response has not been elucidated. CD36, a class B scavenger receptor, is expressed on microglia in normal and AD brains and binds to β-amyloid fibrils in vitro. We report here that microglia and macrophages, isolated from CD36 null mice, had marked reductions in fibrillar β-amyloid–induced secretion of cytokines, chemokines, and reactive oxygen species. Intraperitoneal and stereotaxic intracerebral injection of fibrillar β-amyloid in CD36 null mice induced significantly less macrophage and microglial recruitment into the peritoneum and brain, respectively, than in wild-type mice. Our data reveal that CD36, a major pattern recognition receptor, mediates microglial and macrophage response to β-amyloid, and imply that CD36 plays a key role in the proinflammatory events associated with AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microglia–Aβ interactions lead to early synapse loss39, production of neurotoxic reactive oxygen and nitrogen species (ROS and RNS), NLRP3 inflammasome activation, and production of proinflammatory cytokines and TNF27,40–42.”
From Microglia in neurodegeneration (2018) · cites this paper as [27]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Microglia express multiple receptors that can bind Aβ and trigger inflammation, such as CD36 (105), TLR2, TLR4, TLR6 (17), and NLRP3 (106)”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [105]
The cited source says what the claim attributes to it.
In the citing paper
“As these cytokines are expressed by microglia in response to fibrillar Aβ33, we decided to further investigate the signaling dynamics of the CCL pathway.”
From Effects of SPI1-mediated transcriptome remodeling on Alzheimer's disease-related phenotypes in mouse models of Aβ amyloidosis (2024) · cites this paper as [33]
In the citing paper
“Fibrillary Aβ (fAβ)-induced secretion of inflammatory factors and the recruitment of microglia /macrophages were significantly reduced in CD36 KO mice [374].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [374]
In the citing paper
“In response to such stimuli, microglia can initiate a neuroinflammatory response which, like peripheral inflammation, includes production of cytokines such as TNF and IL-16,27, and possibly chemokines such as Ccl228, to recruit additional cells and induce them to clear injurious agents and maintain brain homeostasis.”
From Microglia in neurodegeneration (2018) · cites this paper as [27]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,630
Self-citationThe molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Ohashi, K., Burkart, V., Flohé, S., & Kolb, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.558 · Cited by 1,606
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940
McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836 · cited 1×
“These fA deposits lead to an innate host response characterized by the accumulation of activated microglia (2, 27).”
BackgroundScavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727
Combs, C. K., Karlo, J. C., Kao, S.-C., & Landreth, G. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01179.2001 · Cited by 721
Research works printed but not linked: 3
- 1998, Am. J. Pathol., 152, 307
- 1996, Am. J. Pathol., 148, 399
- 1988, Am. J. Pathol., 132, 86
Cited by
Items 201–300 of 554
Cunningham, C., Wilcockson, D. C., Boche, D., & Perry, V. H. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5174-5184.2005 · Cited by 53
Role of Microglia in Modulating Adult Neurogenesis in Health and Neurodegeneration
Al‐Onaizi, M., Al-Khalifah, A., Qasem, D., & ElAli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186875 · Cited by 63
Hao, W., Liu, Y., Liu, S., Walter, S., Grimm, M. O., Kiliaan, A. J., Penke, B., Hartmann, T., Rübe, C. E., Menger, M. D., et al. (2011) · Brain · doi:10.1093/brain/awq325 · Cited by 56
Theoharides, T. C., Twahir, A., & Kempuraj, D. (2023) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2023.10.032 · Cited by 60
Kim, E., Tolhurst, A. T., Szeto, H. H., & Cho, S. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12326 · Cited by 60
Takamura, R., Watamura, N., Nikkuni, M., & Ohshima, T. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23843 · Cited by 61
Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression
Koh, H., Lee, S., Lee, H., Min, J.-W., Iwatsubo, T., Teunissen, C., Cho, H.-J., & Ryu, J.-H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313136 · Cited by 53
Pais, T. F., & Chatterjee, S. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.02.009 · Cited by 59
Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles
Deng, Z., Dong, Y., Zhou, X., Lu, J.-H., & Yue, Z. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.009 · Cited by 58
CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke
Cho, S. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802002760 · Cited by 58
CD36 in the periphery and brain synergizes in stroke injury in hyperlipidemia
Kim, E., Febbraio, M., Bao, Y., Tolhurst, A. T., Epstein, J. M., & Cho, S. (2012) · Annals of Neurology · doi:10.1002/ana.23569 · Cited by 58
Sweepers in the CNS: Microglial Migration and Phagocytosis in the Alzheimer Disease Pathogenesis
Noda, M., & Suzumura, A. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/891087 · Cited by 47
Aptamer Technology: Adjunct Therapy for Malaria
Kamarudin, N. A. A. N., Mohammed, N., & Mustaffa, K. M. F. (2017) · Biomedicines · doi:10.3390/biomedicines5010001 · Cited by 57
Ameliorating Amyloid-β Fibrils Triggered Inflammation via Curcumin-Loaded Polymeric Nanoconstructs
Ameruoso, A., Palomba, R., Palange, A. L., Cervadoro, A., Lee, A., Mascolo, D. D., & Decuzzi, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01411 · Cited by 57
Dwellers and Trespassers: Mononuclear Phagocytes at the Borders of the Central Nervous System
Ivan, D. C., Walthert, S., Berve, K., Steudler, J., & Locatelli, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609921 · Cited by 54
Wang, C.-Y., Wang, Z.-Y., Xie, J.-W., Cai, J.-H., Wang, T., Xu, Y., Wang, X., & An, L. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5845 · Cited by 52
Knapskog, A.-B., Henjum, K., Idland, A.-V., Eldholm, R. S., Persson, K., Saltvedt, I., Watne, L. O., Engedal, K., & Nilsson, L. N. G. (2020) · Scientific Reports · doi:10.1038/s41598-020-72878-8 · Cited by 49
Gebbink, M. F. B. G., Bouma, B., Maas, C., & Bouma, B. N. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.06.013 · Cited by 55
Glezer, I., Bittencourt, J. C., & Rivest, S. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22185 · Cited by 55
Doens, D., Valiente, P. A., Mfuh, A. M., Vo, A. X. T., Tristan, A., Carreño, L., Quijada, M. R., Nguyen, V. T., Perry, G. L., Larionov, O. V., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00386 · Cited by 53
Saggu, S., Pless, A., Dew, E., Ware, D., Jiao, K., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1543730 · Cited by 52
CCR6: A Biomarker for Alzheimer's-like Disease in a Triple Transgenic Mouse Model
Subramanian, S., Ayala, P., Wadsworth, T. L., Harris, C. J., Vandenbark, A. A., Quinn, J. F., & Offner, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100852 · Cited by 50
Ito, S., Sawada, M., Haneda, M., Ishida, Y., & Isobe, K. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.07.009 · Cited by 52
Innate Immune Response Gene Expression Profiles of N9 Microglia Are Pathogen-Type Specific
McKimmie, C. S., Roy, D., Forster, T., & Fazakerley, J. K. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.012 · Cited by 51
Teitsdottir, U. D., Jónsdóttir, M. K., Lund, S. H., Darreh‐Shori, T., Snædal, J., & Petersen, P. H. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00657-8 · Cited by 51
Azam, S., Haque, M. E., Kim, I., & Choi, D. (2021) · Cells · doi:10.3390/cells10010150 · Cited by 51
Possible role of scavenger receptor SRCL in the clearance of amyloid‐βin Alzheimer's disease
Nakamura, K., Ohya, W., Funakoshi, H., Sakaguchi, G., Kato, A., Takeda, M., Kudo, T., & Nakamura, T. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20992 · Cited by 46
Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders
Mitra, S., Banik, A., Saurabh, S., Maulik, M., & Khatri, S. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0998-21.2022 · Cited by 50
García-González, P. A., Cabral‐Miranda, F., Hetz, C. A., & Osorio, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02541 · Cited by 50
Two macrophages, osteoclasts and microglia: from development to pleiotropy
Lee, J., Lee, I., Iimura, T., & Kong, S. W. (2021) · Bone Research · doi:10.1038/s41413-020-00134-w · Cited by 50
Role of cytokines and chemokines in prion infections of the central nervous system
Burwinkel, M., Riemer, C., Schwarz, A., Schultz, J., Neidhold, S., Bamme, T., & Baier, M. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.07.017 · Cited by 50
Amyloidosis in Retinal Neurodegenerative Diseases
Masuzzo, A., Dinet, V., Cavanagh, C., Mascarelli, F., & Krantic, S. M. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00127 · Cited by 50
Kunjathoor, V. V., Tseng, A. A., Medeiros, L. A., Khan, T., & Moore, K. J. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-23 · Cited by 49
Self-citationAcylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
Reich, N., & Hölscher, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614828 · Cited by 48
Neuroinflammation in Alzheimer's disease and beneficial action of luteolin
Delgado, A., Cholevas, C., & Theoharides, T. C. (2021) · BioFactors · doi:10.1002/biof.1714 · Cited by 48
Immune dysfunction in Alzheimer disease
Butovsky, O., Rosenzweig, N., Kleemann, K. L., Jorfi, M., Kuchroo, V. K., Tanzi, R. E., & Weiner, H. L. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00997-0 · Cited by 48
Alzheimer’s Disease and Protein Kinases
Engin, A. B., & Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_11 · Cited by 47
Stewart, C. R., Wilson, L. M., Zhang, Q., Pham, C. L. L., Waddington, L. J., Staples, M. K., Stapleton, D., Kelly, J. W., & Howlett, G. J. (2007) · Biochemistry · doi:10.1021/bi602554z · Cited by 47
Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex
Leung, E., Guo, L., Bu, J., Maloof, M., Khoury, J. E., & Geula, C. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.025 · Cited by 40
Neurodegeneration and the neuroimmune system
El Khoury, J. (2010) · Nature Medicine · doi:10.1038/nm1210-1369 · Cited by 46
IL-1R–Associated Kinase-1 Mediates Protein Kinase Cδ-Induced IL-1β Production in Monocytes
Tiwari, R. L., Singh, V., Singh, A., & Barthwal, M. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002526 · Cited by 46
Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress
Silverstein, R. L. (2009) · Clinical Lipidology · doi:10.2217/clp.09.57 · Cited by 46
Reich, N., & Hölscher, C. (2024) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2024.101122 · Cited by 45
Huang, C., Dong, D., Jiao, Q., Pan, H., Ma, L., & Wang, R. (2017) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12697 · Cited by 45
Takata, K., Ginhoux, F., & Shimohama, S. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114754 · Cited by 45
SELENOK-dependent CD36 palmitoylation regulates microglial functions and Aβ phagocytosis
Ouyang, P., Cai, Z., Peng, J., Lin, S., Chen, X., Chen, C., Feng, Z., Wang, L., Song, G.-L., & Zhang, Z. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103064 · Cited by 45
Park, D., Choi, E.-K., Cho, T.-H., Joo, S. S., & Kim, Y.-B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113958 · Cited by 44
Derry, P. J., Vo, A. T. T., Gnanasekaran, A., Mitra, J., Liopo, A. V., Hegde, M. L., Tsai, A., Tour, J. M., & Kent, T. A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.603043 · Cited by 45
NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration
Sita, G., Graziosi, A., Hrelia, P., & Morroni, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136984 · Cited by 44
Gut-brain axis and Alzheimer's disease: Therapeutic interventions and strategies
Singh, H., Chopra, C., Singh, H., Malgotra, V., Wani, A. K., Dhanjal, D. S., Sharma, I., Nepovimová, E., Alomar, S. Y., Singh, R., et al. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105915 · Cited by 43
The Role of Neuroinflammation in Neurodegenerative Disorders
Suescun, J., Chandra, S., & Schiess, M. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813832-8.00013-3 · Cited by 43
Soto-Rojas, L. O., Campa-Córdoba, B. B., Harrington, C. R., Salas‐Casas, A., Hernándes‐Alejandro, M., Villanueva‐Fierro, I., Bravo-Muñoz, M., Garcés‐Ramírez, L., de la Cruz‐López, F., Ontiveros‐Torres, M. Á., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073654 · Cited by 43
Li, X., Melief, E., Postupna, N., Montine, K. S., Keene, C. D., & Montine, T. J. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.09.016 · Cited by 36
Reales‐Calderón, J. A., Sylvester, M., Strijbis, K., Jensen, O. N., Nombela, C., Molero, G., & Gil, C. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.06.026 · Cited by 42
Tajbakhsh, A., Read, M., Barreto, G. E., Ávila-Rodriguez, M., Gheibi-Hayat, S. M., & Sahebkar, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173873 · Cited by 41
Luo, Y., Wang, J., Li, K., Li, M., Xu, S., Liu, X., Zhang, Z., Xu, X. M., Zhang, Y., Pan, J., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00795-6 · Cited by 42
Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model
Wang, Q., Xu, Y., Chen, J., Qin, Y., Liu, M., Liu, Y., Xie, M.-J., Yu, Z., Zhu, Z., & Wang, W. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.011 · Cited by 42
Madadi, S., Schwarzenbach, H., Saidijam, M., Mahjub, R., & Soleimani, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0354-3 · Cited by 41
Xia, L., Zhou, Z., Chen, X., Luo, W., Ding, L., Xie, H., Zhuang, W., Ni, K., & Li, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115834 · Cited by 41
Potential Immunotargets for Alzheimer's Disease Treatment Strategies
Fernández, P. L., Britton, G. B., & Rao, K. S. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-121222 · Cited by 37
Roles of HSV-1 infection-induced microglial immune responses in CNS diseases: friends or foes?
Wang, Y., Jia, J., Wang, Y., Li, F., Song, X., Qin, S., Wang, Z., Kitazato, K., & Wang, Y. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1660615 · Cited by 40
Gebril, H. M., Aryasomayajula, A., de Lima, M. R. N., Uhrich, K. E., & Moghe, P. V. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-023-00393-7 · Cited by 40
Teitsdottir, U. D., Halldórsson, S., Rolfsson, Ó., Lund, S. H., Jónsdóttir, M. K., Snædal, J., & Petersen, P. H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200964 · Cited by 40
Scheffler, K., Stenzel, J., Krohn, M., Lange, C., Hofrichter, J., Schumacher, T., Bruning, T., Plath, A.-S., Walker, L., & Pahnke, J. (2011) · Current Alzheimer Research · doi:10.2174/156720511797633179 · Cited by 37
Genetic Analysis of Innate Immunity
Hoebe, K. H. N., Jiang, Z., Tabeta, K., Du, X., Georgel, P., Crozat, K., & Beutler, B. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)91005-0 · Cited by 40
Feiten, A. F., Dahm, K., Schlepckow, K., van Lengerich, B., Suh, J. H., Reifschneider, A., Wefers, B., Bartos, L. M., Wind-Mark, K., de Weerd, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68706-8 · Cited by 39
Cerebral sterile inflammation in neurodegenerative diseases
Otani, K., & Shichita, T. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00137-4 · Cited by 39
Papadopoulou, P., Polissidis, A., Kythreoti, G., Sagnou, M., Stefanatou, A., & Theoharides, T. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011040 · Cited by 41
Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2018) · BioMed Research International · doi:10.1155/2018/1483791 · Cited by 39
Wang, J., Qin, X., Sun, H., He, M., Lv, Q., Gao, C., He, X., & Liao, H. (2021) · Aging Cell · doi:10.1111/acel.13515 · Cited by 39
Regulation of Platelet Function by Class B Scavenger Receptors in Hyperlipidemia
Zimman, A., & Podrez, E. A. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.207498 · Cited by 39
Peli1 impairs microglial Aβ phagocytosis through promoting C/EBPβ degradation
Xu, J., Yu, T., Pietronigro, E. C., Yuan, J., Arioli, J., Pei, Y., Luo, X., Ye, J., Constantin, G., Mao, C., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000837 · Cited by 38
Kaniowska, D., Wenk, K., Rademacher, P., Weiss, R., Fabian, C., Schulz, I., Guthardt, M., Lange, F., Greiser, S., Schmidt, M., et al. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10261-4 · Cited by 38
CD36 expression and brain function: does CD36 deficiency impact learning ability?
Abumrad, N. A., Ajmal, M., Pothakos, K., & Robinson, J. K. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.09.012 · Cited by 38
Gowda, K., Wu, X., Kumar, S., Febbraio, M., & Gowda, D. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077604 · Cited by 38
T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy
Lustig, G., Cele, S., Karim, F., Derache, A., Ngoepe, A., Khan, K., Gosnell, B. I., Moosa, M. S., Ntshuba, N., Marais, S., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009871 · Cited by 37
CD36-BATF2\MYB Axis Predicts Anti-PD-1 Immunotherapy Response in Gastric Cancer
Jiang, Q., Chen, Z., Meng, F., Zhang, H., Chen, H., Xue, J., Shen, X., Liu, T., Dong, L., Zhang, S., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.87635 · Cited by 37
New insights in drug development for Alzheimer's disease based on microglia function
Qiao, O., Ji, H., Zhang, Y., Zhang, X., Zhang, X., Liu, N., Huang, L., Liu, C., & Gao, W. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111703 · Cited by 35
CD36: A multi‐modal target for acute stroke therapy
Cho, S., & Kim, E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05801.x · Cited by 35
Zu, H., Liu, X.-Y., & Yao, K. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118470 · Cited by 34
The Role of CD36/GPIV in Platelet Biology
Bendas, G., & Schlesinger, M. (2023) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0043-1768935 · Cited by 34
Salajegheh, M. K., Raju, R. P., Schmidt, J., & Dalakas, M. C. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.04.022 · Cited by 34
Lin, Y., Liu, S., Sun, Y., Chen, C., Yang, S., Pei, G., Lin, M., Yu, J., Liu, X., Wang, H., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102286 · Cited by 33
Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy
Javidnia, M., Hebron, M. L., Xin, Y., Kinney, N. G., & Moussa, C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170429 · Cited by 33
Lisak, R. P., Benjamins, J. A., Bealmear, B., Yao, B. W., Land, S. A., Nedelkoska, L., & Skundric, D. S. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1251oa · Cited by 33
Hassan, H., Rawlinson, C., Lan, Y., Jenkins, S. I., & Chen, R. (2025) · Biomolecules · doi:10.3390/biom15111629 · Cited by 33
Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go?
von Bernhardi, R. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1248 · Cited by 28
Sorting Through the Roles of Beclin 1 in Microglia and Neurodegeneration
O’Brien, C. E., & Wyss‐Coray, T. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9519-8 · Cited by 31
Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer
Patten, D. A., Wilkinson, A. L., O'Keeffe, A., & Shetty, S. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1733876 · Cited by 30
Importance of Apolipoprotein A-I in Multiple Sclerosis
Gardner, L. A., & Levin, M. C. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00278 · Cited by 30
The Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
Huang, X., Zhen, J., Dong, S., Zhang, H., Halm‐Lutterodt, N. V., & Yuan, L. (2019) · Food & Function · doi:10.1039/c8fo01713a · Cited by 30
Ito, S., Sawada, M., Haneda, M., Fujii, S., Oh‐hashi, K., Kiuchi, K., Takahashi, M., & Isobe, K. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.048 · Cited by 30
The NeuroImmune System in Alzheimer's Disease: The Glass is Half Full
Hickman, S. E., & El Khoury, J. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129027 · Cited by 29
Takatori, S., Kondo, M., & Tomita, T. (2025) · Inflammation and Regeneration · doi:10.1186/s41232-025-00383-4 · Cited by 29
Ghrelin-Mediated Regeneration and Plasticity After Nervous System Injury
Stoyanova, I. I., & Lutz, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.595914 · Cited by 29
Harada, S., Haruna, Y., Aizawa, F., Matsuura, W., Nakamoto, K., Yamashita, T., Kasuya, F., & Tokuyama, S. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.09.036 · Cited by 29
Is Targeting the Inflammasome a Way Forward for Neuroscience Drug Discovery?
Swanton, T., Cook, J., Beswick, J. A., Freeman, S., Lawrence, C. B., & Brough, D. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218786210 · Cited by 29
Kim, B., Dabin, L. C., Tate, M. D., Karahan, H., Sharify, A. D., Acri, D. J., Al-Amin, M. M., Philtjens, S., Smith, D. C., Wijeratne, H. R. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48484-x · Cited by 28
Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease
Susmitha, G., & Kumar, R. K. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109478 · Cited by 28
Metadata
- Authors
- El Khoury, J. B., Moore, K. J., Means, T. K., Leung, J., Terada, K., Toft, M., Freeman, M. W., & Luster, A. D.
- Affiliations
- 1Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy, and Immunology
- Harvard University (US)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-06-09
- Volume
- 197
- Issue
- 12
- Pages
- 1657-1666
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2193948
- OpenAlex
- W2144479616
- Cited by
- 483
- References
- 34
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 30 · 2023: 26 · 2022: 32 · 2021: 44 · 2020: 33 · 2019: 24 · 2018: 21 · 2017: 21 · 2016: 19 · 2015: 15 · 2014: 27 · 2013: 25 · 2012: 18
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG020255, R01AG20255-01)
- National Heart, Lung, and Blood Institute (R01 HL45098, R01HL045098)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01-DK50305, P01DK050305)
- National Institute of Neurological Disorders and Stroke (NS41330, K08NS041330)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- CD36, amyloid-beta, Alzheimer's disease, microglia, macrophages, innate immune response, pattern recognition receptors, scavenger receptors, neuroinflammation, cytokine production, chemokines, reactive oxygen species, microglial recruitment, amyloid plaques
- MeSH terms
- Alzheimer Disease, Animals, Cell Adhesion, Cells, Cultured, Chemotaxis, Humans, Immunohistochemistry, Interleukin-1, Mice, Inbred C57BL, Tumor Necrosis Factor-alpha, Amyloid beta-Peptides, Reactive Oxygen Species, Microglia, Macrophages, Peritoneal, Mice, Knockout, Chemokines, Chemokine CCL2, CD36 Antigens, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.